{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T05:53:08Z","timestamp":1791611588907,"version":"4.3.4"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,4,24]],"date-time":"2018-04-24T00:00:00Z","timestamp":1524528000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,4,24]],"date-time":"2018-04-24T00:00:00Z","timestamp":1524528000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Acid ceramidase (aCDase, <jats:italic>ASAH1<\/jats:italic>) hydrolyzes lysosomal membrane ceramide into sphingosine, the backbone of all sphingolipids, to regulate many cellular processes. Abnormal function of aCDase leads to Farber disease, spinal muscular atrophy with progressive myoclonic epilepsy, and is associated with Alzheimer\u2019s, diabetes, and cancer. Here, we present crystal structures of mammalian aCDases in both proenzyme and autocleaved forms. In the proenzyme, the catalytic center is buried and protected from solvent. Autocleavage triggers a conformational change exposing a hydrophobic channel leading to the active site. Substrate modeling suggests distinct catalytic mechanisms for substrate hydrolysis versus autocleavage. A hydrophobic surface surrounding the substrate binding channel appears to be a site of membrane attachment where the enzyme accepts substrates facilitated by the accessory protein, saposin-D. Structural mapping of disease mutations reveals that most would destabilize the protein fold. These results will inform the rational design of aCDase inhibitors and recombinant aCDase for disease therapeutics.<\/jats:p>","DOI":"10.1038\/s41467-018-03844-2","type":"journal-article","created":{"date-parts":[[2018,4,18]],"date-time":"2018-04-18T10:48:20Z","timestamp":1524048500000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":103,"title":["Structural basis for the activation of acid ceramidase"],"prefix":"10.1038","volume":"9","author":[{"given":"Ahmad","family":"Gebai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6236-4633","authenticated-orcid":false,"given":"Alexei","family":"Gorelik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zixian","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katalin","family":"Illes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9869-2110","authenticated-orcid":false,"given":"Bhushan","family":"Nagar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,4,24]]},"reference":[{"key":"3844_CR1","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.imlet.2017.07.004","volume":"188","author":"D Rigante","year":"2017","unstructured":"Rigante, D., Cipolla, C., Basile, U., Gulli, F. & Savastano, M. C. Overview of immune abnormalities in lysosomal storage disorders. Immunol. Lett. 188, 79\u201385 (2017).","journal-title":"Immunol. Lett."},{"key":"3844_CR2","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1126\/science.1174621","volume":"327","author":"D Lingwood","year":"2010","unstructured":"Lingwood, D. & Simons, K. Lipid rafts as a membrane-organizing principle. Science 327, 46\u201350 (2010).","journal-title":"Science"},{"key":"3844_CR3","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.plipres.2014.01.004","volume":"54","author":"BM Castro","year":"2014","unstructured":"Castro, B. M., Prieto, M. & Silva, L. C. Ceramide: a simple sphingolipid with unique biophysical properties. Prog. Lipid Res. 54, 53\u201367 (2014).","journal-title":"Prog. Lipid Res."},{"key":"3844_CR4","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1016\/j.bbadis.2016.05.001","volume":"1862","author":"EH Schuchman","year":"2016","unstructured":"Schuchman, E. H. Acid ceramidase and the treatment of ceramide diseases: The expanding role of enzyme replacement therapy. Biochim. Biophys. Acta 1862, 1459\u20131471 (2016).","journal-title":"Biochim. Biophys. Acta"},{"key":"3844_CR5","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/j.bbalip.2008.06.002","volume":"1781","author":"C Mao","year":"2008","unstructured":"Mao, C. & Obeid, L. M. Ceramidases: regulators of cellular responses mediated by ceramide, sphingosine, and sphingosine-1-phosphate. Biochim. Biophys. Acta 1781, 424\u2013434 (2008).","journal-title":"Biochim. Biophys. Acta"},{"key":"3844_CR6","doi-asserted-by":"publisher","first-page":"7324","DOI":"10.1074\/jbc.M508382200","volume":"281","author":"M Kono","year":"2006","unstructured":"Kono, M. et al. Neutral ceramidase encoded by the Asah2 gene is essential for the intestinal degradation of sphingolipids. J. Biol. Chem. 281, 7324\u20137331 (2006).","journal-title":"J. Biol. Chem."},{"key":"3844_CR7","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1038\/sj.jid.5701025","volume":"128","author":"W Sun","year":"2008","unstructured":"Sun, W. et al. Upregulation of the human alkaline ceramidase 1 and acid ceramidase mediates calcium-induced differentiation of epidermal keratinocytes. J. Invest. Dermatol. 128, 389\u2013397 (2008).","journal-title":"J. Invest. Dermatol."},{"key":"3844_CR8","doi-asserted-by":"crossref","first-page":"18440","DOI":"10.18632\/oncotarget.7825","volume":"7","author":"R Xu","year":"2016","unstructured":"Xu, R. et al. Alkaline ceramidase 2 and its bioactive product sphingosine are novel regulators of the DNA damage response. Oncotarget 7, 18440\u201318457 (2016).","journal-title":"Oncotarget"},{"key":"3844_CR9","doi-asserted-by":"publisher","first-page":"7964","DOI":"10.1074\/jbc.M109.063586","volume":"285","author":"W Hu","year":"2010","unstructured":"Hu, W. et al. Alkaline ceramidase 3 (ACER3) hydrolyzes unsaturated long-chain ceramides, and its down-regulation inhibits both cell proliferation and apoptosis. J. Biol. Chem. 285, 7964\u20137976 (2010).","journal-title":"J. Biol. Chem."},{"key":"3844_CR10","doi-asserted-by":"crossref","first-page":"3724","DOI":"10.1016\/S0021-9258(18)99832-7","volume":"241","author":"S Gatt","year":"1966","unstructured":"Gatt, S. Enzymatic hydrolysis of sphingolipids. I. Hydrolysis and synthesis of ceramides by an enzyme from rat brain. J. Biol. Chem. 241, 3724\u20133730 (1966).","journal-title":"J. Biol. Chem."},{"key":"3844_CR11","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1126\/science.178.4065.1100","volume":"178","author":"M Sugita","year":"1972","unstructured":"Sugita, M., Dulaney, J. T. & Moser, H. W. Ceramidase deficiency in Farber\u2019s disease (lipogranulomatosis). Science 178, 1100\u20131102 (1972).","journal-title":"Science"},{"key":"3844_CR12","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.ajhg.2012.05.001","volume":"91","author":"J Zhou","year":"2012","unstructured":"Zhou, J. et al. Spinal muscular atrophy associated with progressive myoclonic epilepsy is caused by mutations in ASAH1. Am. J. Hum. Genet. 91, 5\u201314 (2012).","journal-title":"Am. J. Hum. Genet."},{"key":"3844_CR13","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1016\/0002-9343(69)90202-2","volume":"47","author":"HW Moser","year":"1969","unstructured":"Moser, H. W., Prensky, A. L., Wolfe, H. J. & Rosman, N. P. Farber\u2019s lipogranulomatosis. Report of a case and demonstration of an excess of free ceramide and ganglioside. Am. J. Med. 47, 869\u2013890 (1969).","journal-title":"Am. J. Med."},{"key":"3844_CR14","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1002\/ana.410060309","volume":"6","author":"J Jankovic","year":"1979","unstructured":"Jankovic, J. & Rivera, V. M. Hereditary myoclonus and progressive distal muscular atrophy. Ann. Neurol. 6, 227\u2013231 (1979).","journal-title":"Ann. Neurol."},{"key":"3844_CR15","doi-asserted-by":"publisher","first-page":"28200","DOI":"10.1074\/jbc.M110.216382","volume":"286","author":"C Bedia","year":"2011","unstructured":"Bedia, C., Casas, J., Andrieu-Abadie, N., Fabri\u00e0s, G. & Levade, T. Acid ceramidase expression modulates the sensitivity of A375 melanoma cells to dacarbazine. J. Biol. Chem. 286, 28200\u201328209 (2011).","journal-title":"J. Biol. Chem."},{"key":"3844_CR16","doi-asserted-by":"publisher","first-page":"2422","DOI":"10.1074\/jbc.M115.666909","volume":"291","author":"N Realini","year":"2016","unstructured":"Realini, N. et al. Acid ceramidase in melanoma. J. Biol. Chem. 291, 2422\u20132434 (2016).","journal-title":"J. Biol. Chem."},{"key":"3844_CR17","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/s002800000140","volume":"46","author":"S Mehta","year":"2000","unstructured":"Mehta, S. et al. Combined cytotoxic action of paclitaxel and ceramide against the human Tu138 head and neck squamous carcinoma cell line. Cancer Chemother. Pharmacol. 46, 85\u201392 (2000).","journal-title":"Cancer Chemother. Pharmacol."},{"key":"3844_CR18","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.ejca.2015.10.056","volume":"52","author":"JL Roh","year":"2016","unstructured":"Roh, J.-L., Park, J. Y., Kim, E. H. & Jang, H. J. Targeting acid ceramidase sensitises head and neck cancer to cisplatin. Eur. J. Cancer 52, 163\u2013172 (2016).","journal-title":"Eur. J. Cancer"},{"key":"3844_CR19","doi-asserted-by":"crossref","first-page":"83208","DOI":"10.18632\/oncotarget.13079","volume":"7","author":"SF Tan","year":"2016","unstructured":"Tan, S.-F. et al. Acid ceramidase is upregulated in AML and represents a novel therapeutic target. Oncotarget 7, 83208\u201383222 (2016).","journal-title":"Oncotarget"},{"key":"3844_CR20","doi-asserted-by":"publisher","first-page":"3489","DOI":"10.1111\/j.1460-9568.2004.03852.x","volume":"20","author":"Y Huang","year":"2004","unstructured":"Huang, Y. et al. Elevation of the level and activity of acid ceramidase in Alzheimer\u2019s disease brain. Eur. J. Neurosci. 20, 3489\u20133497 (2004).","journal-title":"Eur. J. Neurosci."},{"key":"3844_CR21","doi-asserted-by":"publisher","first-page":"20148","DOI":"10.1074\/jbc.M412769200","volume":"280","author":"JA Chavez","year":"2005","unstructured":"Chavez, J. A., Holland, W. L., B\u00e4r, J., Sandhoff, K. & Summers, S. A. Acid ceramidase overexpression prevents the inhibitory effects of saturated fatty acids on insulin signaling. J. Biol. Chem. 280, 20148\u201320153 (2005).","journal-title":"J. Biol. Chem."},{"key":"3844_CR22","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1080\/14728222.2017.1322065","volume":"21","author":"SF Tan","year":"2017","unstructured":"Tan, S.-F., Pearson, J. M., Feith, D. J. & Loughran, T. P. The emergence of acid ceramidase as a therapeutic target for acute myeloid leukemia. Expert. Opin. Ther. Targets 21, 583\u2013590 (2017).","journal-title":"Expert. Opin. Ther. Targets"},{"key":"3844_CR23","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1002\/emmm.201202301","volume":"5","author":"AM Alayoubi","year":"2013","unstructured":"Alayoubi, A. M. et al. Systemic ceramide accumulation leads to severe and varied pathological consequences. EMBO Mol. Med. 5, 827\u2013842 (2013).","journal-title":"EMBO Mol. Med."},{"key":"3844_CR24","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.bbacli.2017.02.001","volume":"7","author":"X He","year":"2017","unstructured":"He, X. et al. Enzyme replacement therapy for Farber disease: proof-of-concept studies in cells and mice. BBA Clin. 7, 85\u201396 (2017).","journal-title":"BBA Clin."},{"key":"3844_CR25","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1515\/BC.2007.152","volume":"388","author":"H Schulze","year":"2007","unstructured":"Schulze, H., Schepers, U. & Sandhoff, K. Overexpression and mass spectrometry analysis of mature human acid ceramidase. Biol. Chem. 388, 1333\u20131343 (2007).","journal-title":"Biol. Chem."},{"key":"3844_CR26","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1110\/ps.0240803","volume":"12","author":"J Pei","year":"2003","unstructured":"Pei, J. & Grishin, N. V. Peptidase family U34 belongs to the superfamily of N-terminal nucleophile hydrolases. Protein Sci. 12, 1131\u20131135 (2003).","journal-title":"Protein Sci."},{"key":"3844_CR27","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1038\/378416a0","volume":"378","author":"JA Brannigan","year":"1995","unstructured":"Brannigan, J. A. et al. A protein catalytic framework with an N-terminal nucleophile is capable of self-activation. Nature 378, 416\u2013419 (1995).","journal-title":"Nature"},{"key":"3844_CR28","doi-asserted-by":"publisher","first-page":"11098","DOI":"10.1074\/jbc.270.19.11098","volume":"270","author":"K Bernardo","year":"1995","unstructured":"Bernardo, K. et al. Purification, characterization, and biosynthesis of human acid ceramidase. J. Biol. Chem. 270, 11098\u201311102 (1995).","journal-title":"J. Biol. Chem."},{"key":"3844_CR29","doi-asserted-by":"publisher","first-page":"11253","DOI":"10.1074\/jbc.M709166200","volume":"283","author":"N Shtraizent","year":"2008","unstructured":"Shtraizent, N. et al. Autoproteolytic cleavage and activation of human acid ceramidase. J. Biol. Chem. 283, 11253\u201311259 (2008).","journal-title":"J. Biol. Chem."},{"key":"3844_CR30","doi-asserted-by":"publisher","first-page":"2329","DOI":"10.1110\/ps.9.12.2329","volume":"9","author":"C Oinonen","year":"2000","unstructured":"Oinonen, C. & Rouvinen, J. Structural comparison of Ntn-hydrolases. Protein Sci. 9, 2329\u20132337 (2000).","journal-title":"Protein Sci."},{"key":"3844_CR31","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1006\/abbi.1994.1248","volume":"311","author":"N Azuma","year":"1994","unstructured":"Azuma, N., O\u2019Brien, J. S., Moser, H. W. & Kishimoto, Y. Stimulation of acid ceramidase activity by saposin D. Arch. Biochem. Biophys. 311, 354\u2013357 (1994).","journal-title":"Arch. Biochem. Biophys."},{"key":"3844_CR32","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/s00249-012-0858-9","volume":"42","author":"B Olmeda","year":"2013","unstructured":"Olmeda, B., Garc\u00eda-\u00c1lvarez, B. & P\u00e9rez-Gil, J. Structure\u2013function correlations of pulmonary surfactant protein SP-B and the saposin-like family of proteins. Eur. Biophys. J. 42, 209\u2013222 (2013).","journal-title":"Eur. Biophys. J."},{"key":"3844_CR33","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1073\/pnas.0136947100","volume":"100","author":"VE Ahn","year":"2003","unstructured":"Ahn, V. E., Faull, K. F., Whitelegge, J. P., Fluharty, A. L. & Prive, G. G. Crystal structure of saposin B reveals a dimeric shell for lipid binding. Proc. Natl Acad. Sci. USA 100, 38\u201343 (2003).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"3844_CR34","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1002\/pro.5560040415","volume":"4","author":"S Weiler","year":"2008","unstructured":"Weiler, S., Tomich, J. M., Kishimoto, Y., O\u2019Brien, J. S. & Barranger, J. A. Identification of the binding and activating sites of the sphingolipid activator protein, saposin C, with glucocerebrosidase. Protein Sci. 4, 756\u2013764 (2008).","journal-title":"Protein Sci."},{"key":"3844_CR35","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1042\/bj20030359","volume":"373","author":"F Ciaffoni","year":"2003","unstructured":"Ciaffoni, F., Tatti, M., Salvioli, R. & Vaccaro, A. M. Interaction of saposin D with membranes: effect of anionic phospholipids and sphingolipids. Biochem. J. 373, 785\u2013792 (2003).","journal-title":"Biochem. J."},{"key":"3844_CR36","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1016\/j.str.2008.02.016","volume":"16","author":"M Rossmann","year":"2008","unstructured":"Rossmann, M. et al. Crystal structures of human saposins C and D: implications for lipid recognition and membrane interactions. Structure 16, 809\u2013817 (2008).","journal-title":"Structure"},{"key":"3844_CR37","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1107\/S0907444908003120","volume":"64","author":"K Popovic","year":"2008","unstructured":"Popovic, K. & Priv\u00e9, G. G. Structures of the human ceramide activator protein saposin D. Acta Crystallogr. Sect. D Biol. Crystallogr. 64, 589\u2013594 (2008).","journal-title":"Acta Crystallogr. Sect. D Biol. Crystallogr."},{"key":"3844_CR38","doi-asserted-by":"publisher","first-page":"35352","DOI":"10.1074\/jbc.M103066200","volume":"276","author":"K Ferlinz","year":"2001","unstructured":"Ferlinz, K. et al. Human acid ceramidase. J. Biol. Chem. 276, 35352\u201335360 (2001).","journal-title":"J. Biol. Chem."},{"key":"3844_CR39","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1038\/8213","volume":"6","author":"CG Suresh","year":"1999","unstructured":"Suresh, C. G. et al. Penicillin V acylase crystal structure reveals new Ntn-hydrolase family members. Nat. Struct. Biol. 6, 414\u2013416 (1999).","journal-title":"Nat. Struct. Biol."},{"key":"3844_CR40","doi-asserted-by":"publisher","first-page":"29948","DOI":"10.1074\/jbc.M303310200","volume":"278","author":"N Okino","year":"2003","unstructured":"Okino, N. et al. The reverse activity of human acid ceramidase. J. Biol. Chem. 278, 29948\u201329953 (2003).","journal-title":"J. Biol. Chem."},{"key":"3844_CR41","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.str.2010.01.005","volume":"18","author":"M Bokhove","year":"2010","unstructured":"Bokhove, M. et al. Structures of an isopenicillin N converting Ntn-hydrolase reveal different catalytic roles for the active site residues of precursor and mature enzyme. Structure 18, 301\u2013308 (2010).","journal-title":"Structure"},{"key":"3844_CR42","doi-asserted-by":"publisher","first-page":"5760","DOI":"10.1074\/jbc.M006846200","volume":"276","author":"T Linke","year":"2001","unstructured":"Linke, T. et al. Interfacial regulation of acid ceramidase activity. J. Biol. Chem. 276, 5760\u20135768 (2001).","journal-title":"J. Biol. Chem."},{"key":"3844_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00439-013-1358-4","volume":"133","author":"PD Stenson","year":"2014","unstructured":"Stenson, P. D. et al. The human gene mutation database: building a comprehensive mutation repository for clinical and molecular genetics, diagnostic testing and personalized genomic medicine. Hum. Genet. 133, 1\u20139 (2014).","journal-title":"Hum. Genet."},{"key":"3844_CR44","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1016\/j.str.2015.06.013","volume":"23","author":"MV Airola","year":"2015","unstructured":"Airola, M. V. et al. Structural basis for ceramide recognition and hydrolysis by human neutral ceramidase. Structure 23, 1482\u20131491 (2015).","journal-title":"Structure"},{"key":"3844_CR45","doi-asserted-by":"publisher","first-page":"21508","DOI":"10.1074\/jbc.M002522200","volume":"275","author":"S El Bawab","year":"2000","unstructured":"El Bawab, S. et al. Molecular cloning and characterization of a human mitochondrial ceramidase. J. Biol. Chem. 275, 21508\u201321513 (2000).","journal-title":"J. Biol. Chem."},{"key":"3844_CR46","doi-asserted-by":"publisher","first-page":"11229","DOI":"10.1074\/jbc.275.15.11229","volume":"275","author":"M Tani","year":"2000","unstructured":"Tani, M. et al. Molecular cloning of the full-length cDNA encoding mouse neutral ceramidase. A novel but highly conserved gene family of neutral\/alkaline ceramidases. J. Biol. Chem. 275, 11229\u201311234 (2000).","journal-title":"J. Biol. Chem."},{"key":"3844_CR47","doi-asserted-by":"publisher","first-page":"2823","DOI":"10.1074\/jbc.M108888200","volume":"277","author":"Y Kim","year":"2002","unstructured":"Kim, Y., Kim, S., Earnest, T. N. & Hol, W. G. J. Precursor structure of cephalosporin acylase. J. Biol. Chem. 277, 2823\u20132829 (2002).","journal-title":"J. Biol. Chem."},{"key":"3844_CR48","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1074\/jbc.M309281200","volume":"279","author":"J Yoon","year":"2004","unstructured":"Yoon, J. et al. A bound water molecule is crucial in initiating autocatalytic precursor activation in an N-terminal hydrolase. J. Biol. Chem. 279, 341\u2013347 (2004).","journal-title":"J. Biol. Chem."},{"key":"3844_CR49","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1006\/jmbi.1998.1818","volume":"279","author":"L Ditzel","year":"1998","unstructured":"Ditzel, L. et al. Conformational constraints for protein self-cleavage in the proteasome. J. Mol. Biol. 279, 1187\u20131191 (1998).","journal-title":"J. Mol. Biol."},{"key":"3844_CR50","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1016\/S0092-8674(00)80052-5","volume":"98","author":"Q Xu","year":"1999","unstructured":"Xu, Q., Buckley, D., Guan, C. & Guo, H. C. Structural insights into the mechanism of intramolecular proteolysis. Cell 98, 651\u2013661 (1999).","journal-title":"Cell"},{"key":"3844_CR51","doi-asserted-by":"publisher","first-page":"3462","DOI":"10.1074\/jbc.275.5.3462","volume":"275","author":"M Tani","year":"2000","unstructured":"Tani, M. et al. Purification and characterization of a neutral ceramidase from mouse liver. A single protein catalyzes the reversible reaction in which ceramide is both hydrolyzed and synthesized. J. Biol. Chem. 275, 3462\u20133468 (2000).","journal-title":"J. Biol. Chem."},{"key":"3844_CR52","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1016\/j.febslet.2009.10.021","volume":"584","author":"T Kolter","year":"2010","unstructured":"Kolter, T. & Sandhoff, K. Lysosomal degradation of membrane lipids. FEBS Lett. 584, 1700\u20131712 (2010).","journal-title":"FEBS Lett."},{"key":"3844_CR53","doi-asserted-by":"publisher","first-page":"4751","DOI":"10.1016\/j.febslet.2006.07.071","volume":"580","author":"S Elojeimy","year":"2006","unstructured":"Elojeimy, S. et al. New insights on the use of desipramine as an inhibitor for acid ceramidase. FEBS Lett. 580, 4751\u20134756 (2006).","journal-title":"FEBS Lett."},{"key":"3844_CR54","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/0005-2760(89)90274-9","volume":"1004","author":"BJ Al","year":"1989","unstructured":"Al, B. J. et al. Properties of acid ceramidase from human spleen. Biochim. Biophys. Acta 1004, 245\u2013251 (1989).","journal-title":"Biochim. Biophys. Acta"},{"key":"3844_CR55","doi-asserted-by":"publisher","first-page":"30576","DOI":"10.1074\/jbc.270.51.30576","volume":"270","author":"AM Vaccaro","year":"1995","unstructured":"Vaccaro, A. M. et al. pH-dependent conformational properties of saposins and their interactions with phospholipid membranes. J. Biol. Chem. 270, 30576\u201330580 (1995).","journal-title":"J. Biol. Chem."},{"key":"3844_CR56","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-02361-y","volume":"9","author":"CH Hill","year":"2018","unstructured":"Hill, C. H. et al. The mechanism of glycosphingolipid degradation revealed by a GALC-SapA complex structure. Nat. Commun. 9, 151 (2018).","journal-title":"Nat. Commun."},{"key":"3844_CR57","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms12196","volume":"7","author":"A Gorelik","year":"2016","unstructured":"Gorelik, A., Illes, K., Heinz, L. X., Superti-Furga, G. & Nagar, B. Crystal structure of mammalian acid sphingomyelinase. Nat. Commun. 7, 12196 (2016).","journal-title":"Nat. Commun."},{"key":"3844_CR58","doi-asserted-by":"publisher","first-page":"3026","DOI":"10.1016\/j.jmb.2016.06.012","volume":"428","author":"ZJ Xiong","year":"2016","unstructured":"Xiong, Z.-J., Huang, J., Poda, G., Pom\u00e8s, R. & Priv\u00e9, G. G. Structure of human acid sphingomyelinase reveals the role of the saposin domain in activating substrate hydrolysis. J. Mol. Biol. 428, 3026\u20133042 (2016).","journal-title":"J. Mol. Biol."},{"key":"3844_CR59","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms13082","volume":"7","author":"YF Zhou","year":"2016","unstructured":"Zhou, Y.-F. et al. Human acid sphingomyelinase structures provide insight to molecular basis of Niemann\u2013Pick disease. Nat. Commun. 7, 13082 (2016).","journal-title":"Nat. Commun."},{"key":"3844_CR60","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/S0076-6879(97)76066-X","volume":"276","author":"Z Otwinowski","year":"1997","unstructured":"Otwinowski, Z. & Minor, W. Processing of X-ray diffraction data collected in oscillation mode. Methods Enzymol. 276, 307\u2013326 (1997).","journal-title":"Methods Enzymol."},{"key":"3844_CR61","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1107\/S0907444909012098","volume":"65","author":"TC Terwilliger","year":"2009","unstructured":"Terwilliger, T. C. et al. Decision-making in structure solution using Bayesian estimates of map quality: the PHENIX AutoSol wizard. Acta Crystallogr. Sect. D Biol. Crystallogr. 65, 582\u2013601 (2009).","journal-title":"Acta Crystallogr. Sect. D Biol. Crystallogr."},{"key":"3844_CR62","first-page":"213","volume-title":"Acta Crystallogr. Sect. D Biol. Crystallogr.","author":"PD Adams","year":"2010","unstructured":"Adams, P. D. et al. PHENIX: a comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr. Sect. D Biol. Crystallogr. 66, 213\u2013221 (2010)."},{"key":"3844_CR63","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1107\/S0907444910007493","volume":"66","author":"P Emsley","year":"2010","unstructured":"Emsley, P., Lohkamp, B., Scott, W. G. & Cowtan, K. Features and development of Coot. Acta Crystallogr. Sect. D Biol. Crystallogr. 66, 486\u2013501 (2010).","journal-title":"Acta Crystallogr. Sect. D Biol. Crystallogr."},{"key":"3844_CR64","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1107\/S0021889807021206","volume":"40","author":"AJ McCoy","year":"2007","unstructured":"McCoy, A. J. et al. Phaser crystallographic software. J. Appl. Crystallogr. 40, 658\u2013674 (2007).","journal-title":"J. Appl. Crystallogr."},{"key":"3844_CR65","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1107\/S0907444912001308","volume":"68","author":"PV Afonine","year":"2012","unstructured":"Afonine, P. V. et al. Towards automated crystallographic structure refinement with phenix.refine. Acta Crystallogr. Sect. D Biol. Crystallogr. 68, 352\u2013367 (2012).","journal-title":"Acta Crystallogr. Sect. D Biol. Crystallogr."},{"key":"3844_CR66","doi-asserted-by":"publisher","first-page":"W665","DOI":"10.1093\/nar\/gkh381","volume":"32","author":"TJ Dolinsky","year":"2004","unstructured":"Dolinsky, T. J., Nielsen, J. E., McCammon, J. A. & Baker, N. A. PDB2PQR: an automated pipeline for the setup of Poisson-Boltzmann electrostatics calculations. Nucleic Acids Res. 32, W665\u2013W667 (2004).","journal-title":"Nucleic Acids Res."},{"key":"3844_CR67","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.softx.2015.06.001","volume":"1","author":"MJ Abraham","year":"2015","unstructured":"Abraham, M. J. et al. GROMACS: high performance molecular simulations through multi-level parallelism from laptops to supercomputers. SoftwareX 1, 19\u201325 (2015).","journal-title":"SoftwareX"},{"key":"3844_CR68","doi-asserted-by":"publisher","first-page":"1656","DOI":"10.1002\/jcc.20090","volume":"25","author":"C Oostenbrink","year":"2004","unstructured":"Oostenbrink, C., Villa, A., Mark, A. E. & Van Gunsteren, W. F. A biomolecular force field based on the free enthalpy of hydration and solvation: the GROMOS force-field parameter sets 53A5 and 53A6. J. Comput. Chem. 25, 1656\u20131676 (2004).","journal-title":"J. Comput. Chem."},{"key":"3844_CR69","doi-asserted-by":"publisher","first-page":"4026","DOI":"10.1021\/ct200196m","volume":"7","author":"AK Malde","year":"2011","unstructured":"Malde, A. K. et al. An automated force field topology builder (ATB) and repository: version 1.0. J. Chem. Theory Comput. 7, 4026\u20134037 (2011).","journal-title":"J. Chem. Theory Comput."},{"key":"3844_CR70","doi-asserted-by":"publisher","first-page":"34117","DOI":"10.1063\/1.3446812","volume":"133","author":"H Wang","year":"2010","unstructured":"Wang, H., Dommert, F. & Holm, C. Optimizing working parameters of the smooth particle mesh Ewald algorithm in terms of accuracy and efficiency. J. Chem. Phys. 133, 34117 (2010).","journal-title":"J. Chem. Phys."},{"key":"3844_CR71","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/nmeth.2089","volume":"9","author":"CA Schneider","year":"2012","unstructured":"Schneider, C. A., Rasband, W. S. & Eliceiri, K. W. NIH Image to ImageJ: 25 years of image analysis. Nat. Methods 9, 671\u2013675 (2012).","journal-title":"Nat. Methods"},{"key":"3844_CR72","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1002\/mrd.22489","volume":"82","author":"J Schindelin","year":"2015","unstructured":"Schindelin, J., Rueden, C. T., Hiner, M. C. & Eliceiri, K. W. The ImageJ ecosystem: an open platform for biomedical image analysis. Mol. Reprod. Dev. 82, 518\u2013529 (2015).","journal-title":"Mol. Reprod. Dev."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-018-03844-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-018-03844-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-018-03844-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T13:45:48Z","timestamp":1671543948000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-018-03844-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,24]]},"references-count":72,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["3844"],"URL":"https:\/\/doi.org\/10.1038\/s41467-018-03844-2","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,24]]},"assertion":[{"value":"3 October 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 March 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1621"}}